Appili Therapeutics

About:

Appili Therapeutics is an anti-infective pharmaceutical development company.

Website: http://www.appilitherapeutics.com/

Twitter/X: appili

Top Investors: U.S. Department of Defense, Innovacorp, Atlantic Canada Opportunities Agency, The Lind Partners, National Research Council of Canada Industrial Research Assistance Program

Description:

Appili Therapeutics is an anti-infective pharmaceutical development company. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives.

Total Funding Amount:

$63.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Halifax, Nova Scotia, Canada

Founded Date:

2015-01-01

Contact Email:

info(AT)appilitherapeutics.com

Founders:

Armand Balboni, Kevin Sullivan, Kimberly Stephens, Yoav Golan

Number of Employees:

11-50

Last Funding Date:

2024-04-26

IPO Status:

Public

Industries:

© 2025 bioDAO.ai